174
Jade Biosciences, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
131
FY23:
124
FY24:
69.7
FY25:
349
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.03
FY22:
3.81
FY23:
3.19
FY24:
3.15
FY25:
0.97
Total assets
Change from FY21 to FY25
millions USD
FY21:
175
FY22:
135
FY23:
127
FY24:
72.8
FY25:
350
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
2.55
FY22:
7.78
FY23:
17.6
FY24:
12.0
FY25:
16.5
(negative)
Change from FY21 to FY25
millions USD
FY21:
0.40
FY22:
0.78
FY23:
0.33
FY24:
108
FY25:
0.72
(positive)
Change from FY21 to FY25
millions USD
FY21:
172
FY22:
127
FY23:
109
FY24:
−46.8
FY25:
333
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
175
FY22:
135
FY23:
127
FY24:
72.8
FY25:
350
All amounts in millions USD